ReP USP - Resultado da busca

Artigo de periodico
The role of dendritic cells in COVID-19 infection (2023)
Wang, Xuying; Miller, Heather; Byazrova, Maria G. ; Candotti, Fabio ; Benlagha, Kamel ; Lei, Jiahui; Filatov, Alexander ; Liu, Chaohong ; Câmara, Niels Olsen Saraiva
Source: Emerging Microbes & Infections. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS DENDRÍTICAS, CITOCINAS, COVID-19, INFECÇÕES POR VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Xuying et al. The role of dendritic cells in COVID-19 infection. Emerging Microbes & Infections, v. 12, n. 1, p. 1-9, 2023Tradução . . Disponível em: https://doi.org/10.1080/22221751.2023.2195019. Acesso em: 07 ago. 2024.
APA
Wang, X., Miller, H., Byazrova, M. G., Candotti, F., Benlagha, K., Lei, J., et al. (2023). The role of dendritic cells in COVID-19 infection. Emerging Microbes & Infections, 12( 1), 1-9. doi:10.1080/22221751.2023.2195019
NLM
Wang X, Miller H, Byazrova MG, Candotti F, Benlagha K, Lei J, Filatov A, Liu C, Câmara NOS. The role of dendritic cells in COVID-19 infection [Internet]. Emerging Microbes & Infections. 2023 ; 12( 1): 1-9.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1080/22221751.2023.2195019
Vancouver
Wang X, Miller H, Byazrova MG, Candotti F, Benlagha K, Lei J, Filatov A, Liu C, Câmara NOS. The role of dendritic cells in COVID-19 infection [Internet]. Emerging Microbes & Infections. 2023 ; 12( 1): 1-9.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1080/22221751.2023.2195019
Artigo de periodico
The role of B cells in COVID-19 infection and vaccination (2022)
Chen, Shiru; Guan, Fei; Candotti, Fabio ; Benlagha, Kamel ; Câmara, Niels Olsen Saraiva
Source: Frontiers in Immunology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHEN, Shiru et al. The role of B cells in COVID-19 infection and vaccination. Frontiers in Immunology, v. 13, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.988536. Acesso em: 07 ago. 2024.
APA
Chen, S., Guan, F., Candotti, F., Benlagha, K., & Câmara, N. O. S. (2022). The role of B cells in COVID-19 infection and vaccination. Frontiers in Immunology, 13, 1-13. doi:10.3389/fimmu.2022.988536
NLM
Chen S, Guan F, Candotti F, Benlagha K, Câmara NOS. The role of B cells in COVID-19 infection and vaccination [Internet]. Frontiers in Immunology. 2022 ; 13 1-13.[citado 2024 ago. 07 ] Available from: https://doi.org/10.3389/fimmu.2022.988536
Vancouver
Chen S, Guan F, Candotti F, Benlagha K, Câmara NOS. The role of B cells in COVID-19 infection and vaccination [Internet]. Frontiers in Immunology. 2022 ; 13 1-13.[citado 2024 ago. 07 ] Available from: https://doi.org/10.3389/fimmu.2022.988536
Artigo de periodico
The interaction of SET and protein phosphatase 2A as target for cancer therapy (2021)
Dacol, Emily Cabral ; Wang, S.; Chen, Y.; Lepique, Ana Paula
Source: Biochimica et Biophysica Acta. Reviews on Cancer. Unidade: ICB
Subjects: IMUNOLOGIA, PROTEÍNAS QUINASES, NEOPLASIAS, PROTEÍNAS, CÉLULAS CULTIVADAS DE TUMOR, FOSFATOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DACOL, Emily Cabral et al. The interaction of SET and protein phosphatase 2A as target for cancer therapy. Biochimica et Biophysica Acta. Reviews on Cancer, v. 1876, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bbcan.2021.188578. Acesso em: 07 ago. 2024.
APA
Dacol, E. C., Wang, S., Chen, Y., & Lepique, A. P. (2021). The interaction of SET and protein phosphatase 2A as target for cancer therapy. Biochimica et Biophysica Acta. Reviews on Cancer, 1876( 1). doi:10.1016/j.bbcan.2021.188578
NLM
Dacol EC, Wang S, Chen Y, Lepique AP. The interaction of SET and protein phosphatase 2A as target for cancer therapy [Internet]. Biochimica et Biophysica Acta. Reviews on Cancer. 2021 ; 1876( 1):[citado 2024 ago. 07 ] Available from: https://doi.org/10.1016/j.bbcan.2021.188578
Vancouver
Dacol EC, Wang S, Chen Y, Lepique AP. The interaction of SET and protein phosphatase 2A as target for cancer therapy [Internet]. Biochimica et Biophysica Acta. Reviews on Cancer. 2021 ; 1876( 1):[citado 2024 ago. 07 ] Available from: https://doi.org/10.1016/j.bbcan.2021.188578
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 07 ago. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021)
Kawahara, Rebeca ; Chernykh, Anastasia ; Alagesan, Kathirvel ; Bern, Marshall ; Cao, Weiqian ; Chalkley, Robert J. ; Cheng, Kai; Choo, Matthew S. ; Edwards, Nathan ; Goldman, Radoslav ; Hoffmann, Marcus ; Hu, Yingwei ; Huang, Yifan ; Palmisano, Giuseppe
Source: Nature Methods. Unidade: ICB
Subjects: IMUNOLOGIA, GLICOPEPTÍDEOS, ESPECTROMETRIA DE MASSAS, PROTEÔMICA, PROTEÍNAS, VARIAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWAHARA, Rebeca et al. Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis. Nature Methods, v. 18, p. 1304–1316, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41592-021-01309-x. Acesso em: 07 ago. 2024.
APA
Kawahara, R., Chernykh, A., Alagesan, K., Bern, M., Cao, W., Chalkley, R. J., et al. (2021). Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis. Nature Methods, 18, 1304–1316. doi:10.1038/s41592-021-01309-x
NLM
Kawahara R, Chernykh A, Alagesan K, Bern M, Cao W, Chalkley RJ, Cheng K, Choo MS, Edwards N, Goldman R, Hoffmann M, Hu Y, Huang Y, Palmisano G. Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis [Internet]. Nature Methods. 2021 ; 18 1304–1316.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1038/s41592-021-01309-x
Vancouver
Kawahara R, Chernykh A, Alagesan K, Bern M, Cao W, Chalkley RJ, Cheng K, Choo MS, Edwards N, Goldman R, Hoffmann M, Hu Y, Huang Y, Palmisano G. Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis [Internet]. Nature Methods. 2021 ; 18 1304–1316.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1038/s41592-021-01309-x
Artigo de periodico
MiR-23~27~24–mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation (2019)
Wu, Cheng-Jang ; Cho, Sunglim ; Huang, Hsi-Yuan ; Lu, Chun-Hao ; Russ, Jasmin; Cruz, Leilani O.; Cunha, Flavia Franco da ; Chen, Mei-Chi ; Lin, Ling-li; Warner, Lindsey M. ; Liao, Hsin-Kai ; Utzschneider, Daniel T. ; Quon, Sara ; Berner, Jacqueline; Câmara, Niels Olsen Saraiva ; Zehn, Dietmar ; Belmonte, Juan Carlos Izpisua ; Chen, Li-Chen; Huang, Shiang-Fu ; Kuo, Ming-Ling ; Lu, Li-Fan
Source: Science Advances. Unidade: ICB
Subjects: IMUNOLOGIA, LINFÓCITOS T, DIFERENCIAÇÃO CELULAR, IMUNOLOGIA CELULAR, EXPRESSÃO GÊNICA, TRANSCRIÇÃO GÊNICA, MICRORNAS, ÁCIDOS NUCLEICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WU, Cheng-Jang et al. MiR-23~27~24–mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation. Science Advances, v. 5, p. 13 , 2019Tradução . . Disponível em: https://doi.org/10.1126/sciadv.aaw1715. Acesso em: 07 ago. 2024.
APA
Wu, C. -J., Cho, S., Huang, H. -Y., Lu, C. -H., Russ, J., Cruz, L. O., et al. (2019). MiR-23~27~24–mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation. Science Advances, 5, 13 . doi:10.1126/sciadv.aaw1715
NLM
Wu C-J, Cho S, Huang H-Y, Lu C-H, Russ J, Cruz LO, Cunha FF da, Chen M-C, Lin L-li, Warner LM, Liao H-K, Utzschneider DT, Quon S, Berner J, Câmara NOS, Zehn D, Belmonte JCI, Chen L-C, Huang S-F, Kuo M-L, Lu L-F. MiR-23~27~24–mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation [Internet]. Science Advances. 2019 ; 5 13 .[citado 2024 ago. 07 ] Available from: https://doi.org/10.1126/sciadv.aaw1715
Vancouver
Wu C-J, Cho S, Huang H-Y, Lu C-H, Russ J, Cruz LO, Cunha FF da, Chen M-C, Lin L-li, Warner LM, Liao H-K, Utzschneider DT, Quon S, Berner J, Câmara NOS, Zehn D, Belmonte JCI, Chen L-C, Huang S-F, Kuo M-L, Lu L-F. MiR-23~27~24–mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation [Internet]. Science Advances. 2019 ; 5 13 .[citado 2024 ago. 07 ] Available from: https://doi.org/10.1126/sciadv.aaw1715
Artigo de periodico
Kidney disease and obesity: epidemiology, mechanisms and treatment (2017)
Câmara, Niels Olsen Saraiva ; Iseki, Kunitoshi; Kramer, Holly; Liu, Zhi-Hong; Sharma, Kumar
Source: Nature Reviews. Nephrology. Unidade: ICB
Subjects: IMUNOLOGIA, OBESIDADE, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÂMARA, Niels Olsen Saraiva et al. Kidney disease and obesity: epidemiology, mechanisms and treatment. Nature Reviews. Nephrology, v. 13, n. 3, p. 181-190, 2017Tradução . . Disponível em: https://doi.org/10.1038/nrneph.2016.191. Acesso em: 07 ago. 2024.
APA
Câmara, N. O. S., Iseki, K., Kramer, H., Liu, Z. -H., & Sharma, K. (2017). Kidney disease and obesity: epidemiology, mechanisms and treatment. Nature Reviews. Nephrology, 13( 3), 181-190. doi:10.1038/nrneph.2016.191
NLM
Câmara NOS, Iseki K, Kramer H, Liu Z-H, Sharma K. Kidney disease and obesity: epidemiology, mechanisms and treatment [Internet]. Nature Reviews. Nephrology. 2017 ; 13( 3): 181-190.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1038/nrneph.2016.191
Vancouver
Câmara NOS, Iseki K, Kramer H, Liu Z-H, Sharma K. Kidney disease and obesity: epidemiology, mechanisms and treatment [Internet]. Nature Reviews. Nephrology. 2017 ; 13( 3): 181-190.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1038/nrneph.2016.191
Artigo de periodico
Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases (2016)
Conti, Francesca; Reyes, Saul Oswaldo Lugo; Galicia, Lizbeth Blancas; He, Jianxin; Aksu, Güzide; Oliveira Junior, Edgar Borges de; Deswarte, Caroline; Hubeau, Marjorie; Karaca, Neslihan; Suremain, Maylis de; Guérin, Antoine; Baba, Laia Ait; Prando, Carolina; Guerrero, Gloria G; Emiroglu, Melike; Öz, Fatma Nur; Nakashimada, Marco Antonio Yamazaki; Serrano, Edith Gonzalez; Espinosa, Sara; Barlan, Isil; Pérez, Nestor; Regairaz, Lorena; Morales, Héctor Eduardo Guido; Bezrondnik, Liliana; Giovanni, Daniela Di; Dbaibo, Ghassan; Ailal, Fatima; Galicchio, Miguel; Oleastro, Matias; Chemli, Jalel; Danielian, Silvia; Perez, Laura; Ortega, Maria Claudia; Lavin, Susana Soto; Hertecant, Joseph; Anal, Ozden; Kechout, Nadia; Al-Idrissi, Eman; ElGhazali, Gehad; Bondareko, Anastasia; Chernyshova, Liudmyla; Ciznar, Peter; Herbigneaux, Rose-Marie; Diabate, Aminata; Ndaga, Stéphanie; Konte, Barik; Czarna, Ambre; Migaud, Mélanie; Sánchez, Sigifredo Pedraza; Zaidi, Mussaret Bano; Vogt, Guillaume; Blanche, Stéphane; Benmustapha, Imen; Mansouri, Davood; Abel, Laurent; Dupuis, Stéphanie Boisson; Mahlaoui, Nizar; Bousfiha, Ahmed Aziz; Picard, Capucine; Barbouche, Ridha; Al-Muhsen, Saleh; Rosales, Francisco J. Espinosa; Kütükçüler, Necil; Condino Neto, Antonio; Casanova, Jean-Laurent; Bustamante, Jacinta
Source: Journal of Allergy and Clinical Immunology. Unidade: ICB
Subjects: MYCOBACTERIUM, TUBERCULOSE, INFECÇÕES BACTERIANAS E MICOSES, GRANULOMA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONTI, Francesca et al. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. Journal of Allergy and Clinical Immunology, v. 138, n. 1, p. 214-248, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2015.11.041. Acesso em: 07 ago. 2024.
APA
Conti, F., Reyes, S. O. L., Galicia, L. B., He, J., Aksu, G., Oliveira Junior, E. B. de, et al. (2016). Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. Journal of Allergy and Clinical Immunology, 138( 1), 214-248. doi:10.1016/j.jaci.2015.11.041
NLM
Conti F, Reyes SOL, Galicia LB, He J, Aksu G, Oliveira Junior EB de, Deswarte C, Hubeau M, Karaca N, Suremain M de, Guérin A, Baba LA, Prando C, Guerrero GG, Emiroglu M, Öz FN, Nakashimada MAY, Serrano EG, Espinosa S, Barlan I, Pérez N, Regairaz L, Morales HEG, Bezrondnik L, Giovanni DD, Dbaibo G, Ailal F, Galicchio M, Oleastro M, Chemli J, Danielian S, Perez L, Ortega MC, Lavin SS, Hertecant J, Anal O, Kechout N, Al-Idrissi E, ElGhazali G, Bondareko A, Chernyshova L, Ciznar P, Herbigneaux R-M, Diabate A, Ndaga S, Konte B, Czarna A, Migaud M, Sánchez SP, Zaidi MB, Vogt G, Blanche S, Benmustapha I, Mansouri D, Abel L, Dupuis SB, Mahlaoui N, Bousfiha AA, Picard C, Barbouche R, Al-Muhsen S, Rosales FJE, Kütükçüler N, Condino Neto A, Casanova J-L, Bustamante J. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases [Internet]. Journal of Allergy and Clinical Immunology. 2016 ;138( 1): 214-248.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1016/j.jaci.2015.11.041
Vancouver
Conti F, Reyes SOL, Galicia LB, He J, Aksu G, Oliveira Junior EB de, Deswarte C, Hubeau M, Karaca N, Suremain M de, Guérin A, Baba LA, Prando C, Guerrero GG, Emiroglu M, Öz FN, Nakashimada MAY, Serrano EG, Espinosa S, Barlan I, Pérez N, Regairaz L, Morales HEG, Bezrondnik L, Giovanni DD, Dbaibo G, Ailal F, Galicchio M, Oleastro M, Chemli J, Danielian S, Perez L, Ortega MC, Lavin SS, Hertecant J, Anal O, Kechout N, Al-Idrissi E, ElGhazali G, Bondareko A, Chernyshova L, Ciznar P, Herbigneaux R-M, Diabate A, Ndaga S, Konte B, Czarna A, Migaud M, Sánchez SP, Zaidi MB, Vogt G, Blanche S, Benmustapha I, Mansouri D, Abel L, Dupuis SB, Mahlaoui N, Bousfiha AA, Picard C, Barbouche R, Al-Muhsen S, Rosales FJE, Kütükçüler N, Condino Neto A, Casanova J-L, Bustamante J. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases [Internet]. Journal of Allergy and Clinical Immunology. 2016 ;138( 1): 214-248.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1016/j.jaci.2015.11.041
Artigo de periodico
Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery (2016)
Scott, Eric M.; Halees, A.; Itan, Y.; Spencer, E. G.; He,Y.; Azab, M. A.; Gabriel, S. B.; Belkadi, A.; Boisson, B.; Abel, L.; Clark, A. G.; Consortium, Greater Middle East Variome; Alkuraya, F. S.; Casanova, J. L.; Gleeson, J. G.; Rahim, S. A.; Abdel-Hadi, S.; Abdel-Salam, G.; Abdel-Salam, E.; Abdou, M.; Abhytankar, A.; Adimi, P.; Ahmad, J.; Akcakus, M.; Aksu, G.; Hajjar, S. A.; Juamaah, S. A.; Muhsen, S. A.; Sannaa, N. A.; Tameni, S. A.; Al-Aama, J.; Al-Allawi, N.; Al-Baradie, R.; Al-Gazali, L.; Al-Hashem, A.; Al-Herz, W.; Al-Jeaid, D.; Al-Tawari, A.; Alangari, A.; Alcais, A.; AlFawaz, T.; Alsum, Z.; Ammar-Khodja, A.; Amouian, S.; Ammar-Khodja, A.; Arikan, C.; Aryani, O.; Aslanger, A.; Aydogmus, C.; Aytekin, C.; Azam, M.; Bansagi, B.; Barbouche, M. R.; Bastaki, L.; Ben-Omran, T.; Bindu, P. S.; Blancas, L.; Boisson-Dupuis, S.; Bonnet, D.; Stambouli, O. B.; Bousfiha, A.; Boussafara, L.; Boutros, J.; Bustamante, J.; Caksen, H.; Camcioglu, Y.; Catherinot, E.; Celik, F. C.; Ciancanelli, M.; Cipe, F. E.; Clark, G.; Cobat, A.; Comu, S.; Condie, A.; Condino-Neto, A.; Desai, M.; Dobyns, W.; Dogu, F.; Domaia, M.; Egritas, O.; Azbaoui, S. E.; Baghdadi, J. E.; Ruby, M. E.; El-Harouni, A.; Elfeky,R. A.; Elghazali, G.; Faqeih, E.; Fenerci, E.; Fieschi, C.; Funda, C.; Gamal, I.; Gelik, U.; Genel, F.; Gezdirici, A.; Girisha, K. M.; Goldstein, A.; Grattan-Smith, P.; Gupta, N.; Hahn, J.; Hatipoglu, N.; Hennekam, R.; Houshmand, M.; Ichai, P.; Ikinciogullari, A.; Ismail, S.; Jalas, C.; Jouanguy, E.; Kabra, M.; Kalkan, G.; Kara, M.; Karaca, N.; Karaer, K.; Kariminejad, A.; Kayserili, H.; Keser-Emiroglu, M.; Kilic, S. S.; Kissani, N.; Kokron, C.; Koul, R.; Kutukculer, N.; Lanternier, F.; Mahdaviani, A.; Mahlaoui, N.; Mansour, L.; Mansouri, D.; Margari, L.; Valente, E. M.; Marzouki, N.; Masri, A.; Megahed, A.; Megahed, H.; Mekki, N.; Mesdaghi, M.; Mikati, M.; Mojahedi, F.; Mulley, J.; Nampoothiri, S.; Navarrete, C.; Omar, T.; Oraby, A.; Pandaluz, A.; Parvaneh, N.; Patiroglu, T.; Koc, Z. P.; Pellier, I.; Picard, C.; Puel, A.; Raas-Rothschild, A.; Rajab, A.; Raoult, D.; Reisli, I.; Rezaei, N.; Sabri, A.; Sahin, Y.; Saleem, L.; Salem, F.; AlSediq, N. S.; Sanal, O.; Sanger, T.; Shakankiry, H.; Shang, L.; Shehata, N.; Shembesh, N.; Shkalim, V.; Softah, A.; Sogaty, S.; Soliman, N.; Sonmez Aunaci, F.; Sztriha, L.; Taibi-Berrah, L.; Temtamy, S.; Tonekaboni, H.; Trauner, D.; Tuysuz, B.; Varan, A.; Vogt, G.; Walsh, C.; Woods, G.; Yesil, G.; Yildiran, A.; Yildiz, B.; Yuksel, A.; Zaki, M.; Zhang, S. Y.
Source: Nature Genetics. Unidade: ICB
Subjects: VARIAÇÃO GENÉTICA, GENÉTICA, GENÉTICA DE POPULAÇÕES, IMUNOLOGIA, ALELOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCOTT, Eric M. et al. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, v. 48, n. 9, p. 1071-1076, 2016Tradução . . Disponível em: https://doi.org/10.1038/ng.3592. Acesso em: 07 ago. 2024.
APA
Scott, E. M., Halees, A., Itan, Y., Spencer, E. G., He, Y., Azab, M. A., et al. (2016). Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, 48( 9), 1071-1076. doi:10.1038/ng.3592
NLM
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1038/ng.3592
Vancouver
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 ago. 07 ] Available from: https://doi.org/10.1038/ng.3592

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration